The Second Hospital of Lanzhou University

Lanzhou, Gansu 730030

1 studies enrolling now · 1 studies all time

What they study most

Melanoma, Non-small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — Recruiting now